Organization · Private Equity
Hamilton Square Healthcare Partners, LP
Hamilton Square Healthcare Partners, LP is a healthcare investment firm based in Princeton, New Jersey, focusing on healthcare innovation and biotechnology investments.
Overview
What Hamilton Square Healthcare Partners, LP does
What Hamilton Square Healthcare Partners, LP is
Hamilton Square Healthcare Partners, LP is a healthcare investment firm based in Princeton, New Jersey, focusing on healthcare innovation and biotechnology investments.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2025
- Approximate age
- About 1 year
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
Official channels
Find Hamilton Square Healthcare Partners, LP elsewhere
Open the official website or a supported primary organization account.
Capability profile
Hamilton Square Healthcare Partners, LP as a funder
Investment thesis
Hamilton Square Healthcare Partners, LP focuses on investing in healthcare innovation, particularly in later-stage and crossover healthcare and biotech financing.
Focus narrative
Hamilton Square Healthcare Partners, LP specializes in later-stage and crossover investments in healthcare and biotech companies. The firm leverages its deep expertise in public and private healthcare investing to identify opportunities that require clinical development and financing acumen.
Value beyond capital
Hamilton Square Healthcare Partners, LP adds value to its portfolio companies through its team's extensive experience in clinical trial design, M&A, and public market strategies, enabling companies to navigate complex healthcare landscapes effectively.
Focus and fit
- Stages
- Growth Equity · Series C · Series D
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 1
Portfolio context
Notable portfolio company includes Avalyn Pharma, a clinical-stage biopharmaceutical company developing inhaled therapies for pulmonary fibrosis. Hamilton Square Partners Management, LP participated in Avalyn’s oversubscribed USD 100 million Series D financing in July 2025.
Common questions
What to know about Hamilton Square Healthcare Partners, LP
Upseed classifies Hamilton Square Healthcare Partners, LP under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.